3-heteroarylmethyl-imidazo[1,2-b]pyrida zin-6-yl derivatives as C-Met tyrosine kinase modulators

Details for Australian Patent Application No. 2010280706 (hide)

Owner Novartis AG

Inventors Furet, Pascal; McCarthy, Clive; Schoepfer, Joseph; Stutz, Stefan

Agent Davies Collison Cave

Pub. Number AU-A-2010280706

PCT Pub. Number WO2011/015652

Priority 61/273,756 07.08.09 US

Filing date 6 August 2010

Wipo publication date 10 February 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/015652 Priority application(s): WO2011/015652

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010280707-Bioreactor consisting of silicon materials

2010280695-Novel viral replication inhibitors